Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04294563 · ClinicalTrials.gov registry record · NA
Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty
A NA study, sponsored by Auburn University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04294563 is a NA study that was terminated before completion, run by Auburn University. The registered enrollment target is 1 participants.
The verdict
NCT04294563, a NA study, was terminated before completion, sponsored by Auburn University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This randomized controlled trial will study the effects of peanut protein supplementation on changes in muscle size and quality in patients undergoing total knee arthroplasty.
Interventions
- DIETARY_SUPPLEMENT Peanut Protein Powder
- OTHER Standard Care by Surgeon and Physical Therapist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04294563
The ClinicalTrials.gov registry entry for NCT04294563 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peanut Protein Powder is the first listed.
NCT04294563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04294563 about?
NCT04294563 is a clinical study titled "Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty". This randomized controlled trial will study the effects of peanut protein supplementation on changes in muscle size and quality in patients undergoing total knee arthroplasty.
What is the current status of trial NCT04294563?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-08-01. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04294563?
The interventions under investigation include: Peanut Protein Powder (DIETARY_SUPPLEMENT), Standard Care by Surgeon and Physical Therapist (OTHER).
Who is sponsoring clinical trial NCT04294563?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.